Evidence map›Paper›PMID 34596727›Full record

ArticleEuropean journal of clinical pharmacology2022

Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.

Xiaotong Xia, Jinglan Fu, Tingting Wu, Wenjun Chen, Shaojun Jiang, Meina Lv, Jinhua Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xiaotong XiaDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Jinglan FuDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Tingting WuDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Wenjun ChenDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Shaojun JiangDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Meina LvDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Jinhua ZhangDepartment of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. pollyzhang2006@126.com.ORCID http://orcid.org/0000-0002-5629-0348
Fujian Medical University · CN

Funding

Natural Science Foundation of Fujian Province 2018Y0037
6 · The paper itself

Abstract

purposeThe purpose of this study was to analyse the effects of demographic factors, clinical factors, and genetic polymorphisms of related gene loci on warfarin bleeding-related complications in the Han population.

methodsRetrospective medical record review. The study cases were patients treated at the Fujian Medical University Union Hospital from March 2016 to February 2020, and all received regular warfarin anticoagulation treatment for at least 3 months, and were provided the initial standard dose and stable dose of warfarin.

resultsData were collected from 451 qualifying patients (47% male, 53% female). The average age of patients was 53.8 ± 12.2 years, and the average body surface area was 1.6 ± 0.18 m

conclusionsThe ApoE (rs429358) gene polymorphism influences bleeding complications in Chinese Han patients treated with warfarin. The sample size of this study was relatively small; hence an international study with a larger sample size is needed in the future.

Indexed as

AdultAgedAmiodaroneAnti-Arrhythmia AgentsAnticoagulantsApolipoproteins EAsian PeopleBody Surface AreaBody WeightChinaCytochrome P-450 Enzyme InhibitorsEthnicityFemaleGenotypeHemorrhageHumansAmiodaroneAnti-Arrhythmia AgentsAnticoagulantsApoE protein, humanApolipoproteins ECytochrome P-450 Enzyme InhibitorsWarfarinBleeding complicationsDemographic characteristicsGene polymorphismHan populationWarfarin

Identifiers

PMID34596727
OpenAlexW3203705753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.